Unity Biotechnology, Inc. Uncategorized Contracts & Agreements
8 Contracts & Agreements
- Form of Inducement Letter (Filed With SEC on November 13, 2023)
- Amendment to Compound Library and Option Agreement, dated as of February 2, 2016, by and between Ascentage Pharma Group Corp. Ltd. and Unity Biotechnology, Inc (Filed With SEC on March 23, 2021)
- Compound Library and Option Agreement, dated as of February 2, 2016, by and between Ascentage Pharma Group Corp. Ltd. and Unity Biotechnology, Inc (Filed With SEC on March 23, 2021)
- Second Amendment to Compound Library and Option Agreement, dated as of January 8, 2020, by and between Ascentage Pharma Group Corp. Ltd. and Unity Biotechnology, Inc (Filed With SEC on March 11, 2020)
- Description of Unitys Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on March 11, 2020)
- Compound Library and Option Agreement, dated as of February 2, 2016, by and between Ascentage Pharma Group Corp. Ltd. and Unity Biotechnology, Inc (Filed With SEC on April 23, 2018)
- Amendment to Compound Library and Option Agreement, dated as of February 2, 2016, by and between Ascentage Pharma Group Corp. Ltd. and Unity Biotechnology, Inc (Filed With SEC on April 5, 2018)
- Compound Library and Option Agreement, dated as of February 2, 2016, by and between Ascentage Pharma Group Corp. Ltd. and Unity Biotechnology, Inc (Filed With SEC on April 5, 2018)
